OPKO Health and Pathogenics Announce Data Publication Demonstrating the Potential Utility of NCT in a Severe Eye Infection

Feb 25, 2008

OPKO Health Announces Changes to Board of Directors

Jan 25, 2008

OPKO Health to Present at 2008 Wachovia Healthcare Conference

Jan 23, 2008

OPKO Health Appoints Industry Veteran Dr. Naveed Shams as Chief Medical Officer

Jan 14, 2008

OPKO's Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials

Dec 6, 2007

The Frost Group Invests $20 Million in OPKO Health

Dec 5, 2007

OPKO Health Completes Acquisition of Ophthalmic Technologies, Inc.

Nov 29, 2007

OPKO Health Acquires Rights to Innovative Ocular Product to Prevent Serious Eye Infections

Oct 30, 2007

OPKO Health Acquires Rights to Clinical Stage Compound for Dry Eye

Oct 10, 2007

OPKO Health Appoints Pascal J. Goldschmidt to Board of Directors

Oct 1, 2007